May 2024 Letter to Shareholders
VANCOUVER, Washington, May 16, 2024 -- Dear Shareholders, I write today to provide an update on CytoDyn Inc. , as we approach the end of our 2024 fiscal year , and to sincerely thank you for...
Stay updated with breaking news from Jay Lalezari. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VANCOUVER, Washington, May 16, 2024 -- Dear Shareholders, I write today to provide an update on CytoDyn Inc. , as we approach the end of our 2024 fiscal year , and to sincerely thank you for...
Atlanta (Georgia) [US], August 10 (ANI/PRNewswire): Frontier Biotechnologies, a biopharmaceutical company focused on the discovery, development and dissemination of innovative medicines that improve patient health, announced positive results from the Phase 1 clinical trial of its drug candidate, FB2001 - a small molecule inhibitor of coronavirus main protease (Mpro) - in healthy adult volunteers. The data, presented today at the poster session of the 11th International Conference on Emerging Infectious Diseases (ICEID), showed FB2001 to be safe and well tolerated among trial participants. Adve...
VANCOUVER, Washington, May 13, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing...